Purpose: To compare the prevalence of oral high-risk human papillomavirus (HR-HPV) infection between women reporting any lifetime sexual contact with a female partner (WSW) and women reporting exclusively male partners (WSM) in a nationally representative U.S. sample, and to assess how much of the difference is explained by lifetime partner count. Methods: Cross-sectional analysis of women aged 18–69 in the National Health and Nutrition Examination Survey 2009–2016 with evaluated oral HPV genotyping and sexual behavior data. Survey-weighted prevalence was estimated in the full sample. WSW were matched 1:2 to WSM by propensity score on age, smoking, race/ethnicity, and poverty income ratio. Logistic regression in the matched sample additionally adjusted for lifetime partner count (≥10, and four categories). Results: Of 7,943 women, 751 were WSW; 724 (96.4%) of them also reported male partners. Weighted oral HR-HPV prevalence was 2.84% (95% CI 1.57–4.69%) among WSW and 1.04% (0.78–1.35%) among WSM. After matching, WSW had higher odds of infection (OR 2.05, 95% CI 1.15–3.64). WSW reported more lifetime partners (median 12 vs 5), including more male partners (median 10 vs 5). Adjustment for partner count attenuated the association below statistical significance (≥10 partners: OR 1.46, 0.79–2.72). Conclusions: WSW, nearly all of whom also reported male partners, had higher odds of oral HR-HPV infection than demographically matched WSM; lifetime partner count explained part of this difference. A history of female partners should not be taken to imply lower oral HPV risk, and HPV vaccination should be offered according to current recommendations.
No takes yet. Share an insight, caveat, or question.
Meller et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: